Finlee

Finlee (Dabrafenib) is an oral medication used to treat certain types of cancer. This prescription drug is designed to target specific genetic mutations, offering a tailored approach to cancer therapy.

Finlee (Dabrafenib) is primarily used in the treatment of advanced melanoma, a type of skin cancer, that has a specific genetic mutation known as BRAF V600. This medication works by targeting the mutated protein to help slow down the growth and spread of cancer cells. It is often used in combination with other treatments as part of a comprehensive cancer care plan.

Common effects of Finlee (Dabrafenib) may include fatigue, fever, joint pain, and skin reactions. Some individuals might experience changes in hair color or texture. It is important to discuss any persistent or severe side effects with a healthcare provider.

Finlee (Dabrafenib) should be handled with care and stored as directed. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication may cause drowsiness or dizziness, so it is advisable to avoid driving or operating heavy machinery until you know how it affects you.

Finlee (Dabrafenib) can interact with a variety of other medications, including those metabolized by the liver's CYP3A4 enzyme. It is important to inform your healthcare provider about all medications, supplements, and herbal products you are taking to avoid potential interactions. Alcohol consumption should be discussed with your healthcare provider.